Human coronavirus OC43 outbreak in wild chimpanzees, Côte d´Ivoire, 2016 by Patrono, Livia V. et al.
Patrono et al. Emerging Microbes & Infections  (2018) 7:118 Emerging Microbes & Infections
DOI 10.1038/s41426-018-0121-2 www.nature.com/emi
CORRESPONDENCE Open Ac ce s s
Human coronavirus OC43 outbreak in wild
chimpanzees, Côte d´Ivoire, 2016
Livia V. Patrono1, Liran Samuni2,3, Victor M. Corman4,5, Leila Nourifar1, Caroline Röthemeier1, Roman M. Wittig2,3,
Christian Drosten4,5, Sébastien Calvignac-Spencer1 and Fabian H. Leendertz1
Dear Editor,
A number of pathogens have been described to circulate
between humans and non-human primates. The close
relatedness between these hosts is thought to support
pathogen transmission. Due to their rapid spread and
difficult containment, airborne pathogens raise the
greatest concerns. Common human respiratory viruses
such as the human respiratory syncytial virus (HRSV), the
human metapneumovirus (HMPV) and the human rhi-
novirus C, have caused lethal outbreaks in wild habituated
great apes1,2. Strict prevention measures have been
adopted to mitigate the risk of disease introduction at
great ape research sites3, allowing habituation pro-
grammes to maximize positive effects on wildlife con-
servation4. However, transmission of infectious agents
may still occur. Here we report the transmission of the
human coronavirus (HCoV) OC43 to wild chimpanzees
(Pan troglodytes verus) living in the Taï National Park,
Côte d´Ivoire. These chimpanzees are habituated to
human presence, and are in the focus of long-term
observatory studies since the ’80s5. All members of the
three communities (North, South and East) are indivi-
dually known.
Between late December 2016 and early January 2017, a
mild respiratory outbreak was observed in the East
chimpanzee community (currently composed of 33 indi-
viduals). Daily monitoring by trained personnel identified
sporadic coughing and sneezing throughout the group,
mainly in morning hours. No other symptom was
observed. Factors such as forest density, chimpanzee
group fission–fusion and amount of time spent on the
ground vs. on trees strongly influence whether individuals
can be observed on a daily basis. In such conditions, the
detection of disease onset and follow-up of symptoms’
course over time as well as the collection of samples is
very complicated. During this outbreak, symptoms were
reported once in at least nine individuals; of these, six
were consistently identified as symptomatic on three
consecutive days (Fig. 1, bold names). Fecal samples were
collected as part of a continuous non-invasive health
monitoring program6 and shipped to the Robert
Koch Institute for analyses. To expand our window of
investigation to non-outbreak times, a total of 59 samples
collected from 18 individuals of this community between
November 2016 and February 2017 were tested. This
number reflects all available samples for the time frame of
interest. We performed a PCR screening targeting major
respiratory viruses including HRSV and HMPV, adeno-
viruses (AdVs), coronaviruses, enteroviruses, influenza A
and B viruses, parainfluenza viruses and rhinoviruses7,8.
PCR and sequencing identified the HCoV-OC43 in 14/
59 samples, collected from 11 individuals, including those
where symptoms were consistently reported (Fig. 1).
HCoV-OC43 positive samples were collected within the
time frame of observed respiratory disease outbreak,
whereas samples collected before and after were negative.
The detection in feces exclusively during the outbreak
supports the hypothesis of this coronavirus being
responsible for the observed mild respiratory symptoms.
With the exception of AdVs, all other tests were negative.
Adenoviruses were however detected in 49/59 samples
across outbreak and non-outbreak times. Along with the
evidence of AdVs being widely carried by wild great apes
and shed in feces9, the continuous detection points
towards an unlikely involvement in this outbreak.
Since 2008, the Taï Chimpanzee Project has imple-
mented a mandatory quarantine for any individual
intending to approach the chimpanzees10. To control for
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the potential onset of respiratory symptoms, all people
entering the project area remain for 5 days in a camp
separated from those used by research staff and are for-
bidden to enter the forest areas that correspond to
chimpanzees’ territories. Additionally, on quarantine day
1 (QD1) and 5 (QD5), a throat swab is collected and
stored in liquid nitrogen. Upon completion of the fifth
day, individuals that did not develop symptoms can join
the research camps and activities. According to current
measures, swabs are tested for respiratory pathogens only
in the event of an outbreak in the chimpanzees. To
investigate whether HCoV-OC43 was circulating in
humans at the time of the outbreak, 56 swabs collected
between December 2016 and January 2017 were tested.
Four swabs collected on QD1 and QD5 (10 and 14
December 2016, respectively) from two asymptomatic
individuals were positive.
To strengthen epidemiologic links, the following two
techniques were applied in parallel to obtain complete
HCoV-OC43 genomes from feces: (i) a set of 24 nested
PCR assays and sequencing of the amplicons and (ii) an
in-solution hybridization capture approach followed by
next-generation sequencing (supplementary methods).
The two methods yielded comparable results, providing
four complete (GenBank accession numbers MG977444,
MG977445, MG977447 and MG977449) and three nearly
complete viral genomes (GenBank accession numbers
MG977446, MG977448 and MG977450). All consensus
sequences were identical, suggesting that no mutations
arose upon this episode of virus inter-species transmission
and subsequent spread. Viral genome architecture cor-
responded to that previously reported for HCoV-OC43
viruses (supplementary figure 1). Hybridization capture
applied on the HCoV-OC43 positive swabs collected
Fig. 1 Human coronavirus OC43 detection in chimpanzee fecal samples over time. Each line represents an individual. Bold names represent
consistently symptomatic individuals. Gray shadowing indicates the time frame of symptoms’ observation in the group. Vertical grey lines correspond
to the dates in which human quarantine swabs were positive
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during human quarantine (10 December 2016) identified
two complete genomes: one differed from the genomes
determined from chimpanzee fecal samples at 53
nucleotide positions (GenBank accession nr. MG977451)
while the second was completely identical to these same
genomes (GenBank accession nr. MG977452), thus pro-
viding the strongest possible genetic evidence of a local
human-to-chimpanzee transmission. Phylogenetic ana-
lyses showed that the viruses identified in 2016 at Taï
National Park fall within a clade of Asian HCoV-OC43
viruses isolated in 2012/2013 (supplementary figure 2).
The lack of data on HCoVs circulating in Africa, and
more generally the poor geographical sampling of HCoV-
OC43 at any time, hampers a more accurate placement of
these viruses within recent and contemporary strains.
To our knowledge, this is the first report of a HCoV
causing a respiratory anthroponosis in wild great apes.
The HCoV-OC43, which belongs to the species Betacor-
onavirus 1 (BetaCoV1), is an endemic human pathogen
and causes episodes of common cold in humans world-
wide11. Beside in humans, BetaCoV1 strains were detected
in highly divergent host species, including odd- and even-
toed ungulates, carnivores and lagomorphs12. With the
exception of SARS and MERS, human coronaviruses
(HCoV-OC43, -NL63, -HKU1 and -229E) mainly cause
mild infections in healthy individuals. It is therefore
plausible that the virus was inadvertently introduced in
the forest via asymptomatic shedding, overcoming the
threshold of what quarantine per se can prevent. However,
we cannot exclude other human sources of the infection
in the forest, such as poachers.
Except for a recently identified human rhinovirus C in a
wild chimpanzee2, anthroponotic transmissions to chim-
panzees documented over the past decade were exclu-
sively due to members of the virus family Pneumoviridae,
resulting in high morbidities, overt clinical signs and
frequent mortality. Disease severity may have played a
role in raising awareness and attempting non-invasive
monitoring of these specific pathogens. Given the mild
clinical presentation reported here, it seems plausible that
seasonal coronaviruses may have been transmitted to
great apes on other occasions but were not diagnosed.
Outbreak investigation is presumably only possible where
daily observations and continuous sampling for health
monitoring are implemented; overall exposure may
nonetheless be retrospectively investigated using serology
on non-invasive samples13.
Contrary to several previous examples of human
respiratory viruses entering great ape populations, no
mortality was recorded. In fatal HRSV and HMPV out-
breaks, co-infections with opportunistic bacteria such as
Streptococcus pneumoniae were detected and likely
responsible for disease severity14. Despite the limited
amount of the clinical data available for RNA viruses
other than influenza, experimental evidence shows that
infection with HRSV and HMPV favors bacterial coloni-
zation through multiple pathways15. The ability of trig-
gering secondary infections has not been widely reported
nor explored for seasonal coronaviruses, and could
represent an essential factor influencing disease outcome.
The emergence of SARS and MERS has strikingly
changed our perception of coronavirus pathogenicity and
threat. There is no data supporting host-specific CoVs in
great apes and other primates, but this report hints that
anthroponotic transmission of HCoV-OC43 can result in
respiratory disease in chimpanzees, revealing yet a new
interface in coronavirus host switching. Surveillance
programmes implemented for great ape conservation
should thus systematically include coronaviruses. Ulti-
mately, the establishment of on-site diagnostics to detect
asymptomatic shedding could be a valuable asset to
broaden the radius of action of quarantine.
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